Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | KDM1A | O60341 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.53 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.53 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.53 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9513813 | 1.00 | LMNA (0.78) | LMNAKDM1AMAOAMAOBMAPT | |
| SCHEMBL14840114 | 0.88 | LMNA (0.66) | LMNAKDM1AMAOAMAOBMAPT | |
| SCHEMBL50453 | 0.88 | LMNA (1.00) | LMNAMAOACHRNA7CHRNB2CHRNB4 | |
| SCHEMBL3254859 | 0.88 | LMNA (1.00) | LMNAMAOACHRNA7CHRNB2CHRNB4 | |
| SCHEMBL2943775 | 0.88 | LMNA (1.00) | LMNAMAOACHRNA7CHRNB2CHRNB4 | |
| SCHEMBL1618880 | 0.88 | LMNA (1.00) | LMNAMAOACHRNA7CHRNB2CHRNB4 | |
| SCHEMBL5949941 | 0.85 | LMNA (0.78) | LMNAMAPTSMN1; SMN2ADRB2ADRB1 | |
| SCHEMBL4046461 | 0.85 | LMNA (0.85) | LMNAMAOASMN1; SMN2ADRB2ADRB1 | |
| SCHEMBL1496544 | 0.85 | LMNA (0.85) | LMNAMAOASMN1; SMN2ADRB2ADRB1 | |
| SCHEMBL9713476 | 0.85 | LMNA (0.85) | LMNAMAOASMN1; SMN2ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2235684-A | — | — | None | — | — | JP | disclosed |
| EP-2603488-A1 | DIFUNCTIONAL (METH)ACRYLATE WRITING MONOMERS | Bayer Intellectual Property GmbH (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-20120059186-A1 | RADIATION CURABLE COMPOSITIONS | ALLNEX BELGIUM S.A. (BE) | 2012-03-08 | — | — | US | disclosed |
| WO-2012020061-A1 | DIFUNCTIONAL (METH)ACRYLATE WRITING MONOMERS | BAYER MATERIALSCIENCE AG (DE) | 2012-02-16 | — | — | WO | disclosed |
| EP-2267050-A1 | Radiation Curable Compositions | Cytec Surface Specialties, S.A. (BE) | 2010-12-29 | — | — | EP | disclosed |
| JP-H02235684-A | THERMALLY SENSITIVE RECORDING MEDIUM | KAWASAKI KASEI CHEM LTD | 1990-09-18 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059186-A1 | RADIATION CURABLE COMPOSITIONS | XRCC6, XRCC5, RAD51 | LMNA 2146/4885KDM1A 1433/4885MAOA 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.